RESULTS:
Twenty-nine patients (53%) met inclusion/exclusion criteria. Mean age was 57.8 years (SD=13.1), with 22 (75.9%) female patients, and 11 patients (37.9%) with severe CTS. Utilities for the entire cohort was 0.73 (SD=0.09) for SF-6D, 0.75 (SD=0.15) for EQ-5D-5L, 0.94 (SD=0.16) for CG, and 0.74 (SD=0.17) for VAS. Significant difference was found between the severe and non-severe groups for EQ-5D-5L (p=0.01), with utility of 0.64 (S=0.18) for severe and 0.81 (SD=0.07) for non-severe patients. However, this difference was non-significant for SF-6D (p=0.23), CG (p=0.53), and VAS (p=0.67). There was significant inter-instrumental agreement between SF-3D and EQ-5D-5L (Pearson=0.60, p<0.01), SF-3D and VAS (Pearson=0.67, p<0.01), and EQ-5D-5L and VAS (Pearson=0.55, p<0.01). Correlation of CG with the other methods, SF-3D (Pearson=0.18, p=0.34), EQ-5D-5L (Pearson=0.08, p=0.69), and VAS (Pearson=0.08, p=0.70), was not significant.
CONCLUSION:
Utility in this CTS patient population varied from 0.73 to 0.94 depending on the instrument. Variation in utilities between severe versus non-severe patients was significant for EQ-5D-5L only, demonstrating potential limitations in using utility tools to stratify patients according to disease severity. Given that utilities are incorporated as key measures in decision analysis and economic evaluation, the inter-instrument inconsistency found in this study may lead to challenges in constructing valid and reliable models. Future research is needed to determine how to reconcile such inconsistency. , and this will profoundly affect the way in which diseases commonly encountered by plastic surgeons are diagnosed and treated. We recently performed the first ever genome-wide association study (GWAS) of Carpal Tunnel Syndrome (CTS), and identified 13 genome-wide susceptibility loci. The aim of this study was to demonstrate one potential application of our findings.
A Genetic Risk Score for Carpal Tunnel Syndrome

METHODS:
We developed a weighted genetic risk score 2 (wGRS) for CTS based on the genetic variants discovered in our GWAS. We obtained genotypic and diagnostic data from UK Biobank, a prospective cohort study of ~500,000 individuals from the UK who have had whole-genome genotyping undertaken, and have allowed linkage of these data with their medical records. We used ICD-10, OPCS and self-diagnosis codes to identify individuals with CTS and diseases known to be associated with CTS, and investigated whether individuals with certain phenotypes are genetically predisposed to CTS.
RESULTS:
There was a significant difference in wGRS between 12,106 CTS cases (0.326) vs 387,347 non-CTS controls (0.280) (p<0.0001), and also between 11,438 CTS patients who have undergone carpal tunnel surgery (0.328) and 668 CTS patients who have not (0.295) (p=0.00012). We did not observe an increased wGRS in patients with diabetes, rheumatoid arthritis, hypothyroidism and ulnar nerve entrapment. We found a highly statistically significant negative correlation between height and wGRS in both males (r=-0.044, p<0.0001) and females (r=-0.046, p<0.0001), and a weak positive correlation for BMI in males (r=0.0084, p=0.00032) but not in females (r=0.0038, p=0.075).
CONCLUSION:
The significantly higher wGRS in operated CTS patients vs unoperated CTS patients suggests that our wGRS correlates with disease severity. The finding that wGRS is not higher in individuals with diseases known to be associated with CTS suggests that extraneous factors (such as oedema in hypothyroidism and synovitis in rheumatoid arthritis), rather than shared genetic factors, are likely to predispose to CTS in these groups. The negative correlation between wGRS and height explains the observation that CTS patients are on average >2cm shorter than non-CTS controls in the UK Biobank cohort. We are currently extending the wGRS to our own cohort of deeply phenotyped CTS patients, to correlate wGRS with symptoms and electrophysiological test severity, as well as surgical outcomes. We believe it is important for plastic surgeons to be mindful of the increasing role that genetics will play in our practice, and this study illustrates the proof of principle that a wGRS can potentially serve as useful tool in the future for the prognostication of CTS.
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